It is speculated that the TLR9/TGF-β1/PDGF-B pathway may be overactivated in SLE patients, and the overactivation is related to the increased levels of TLR9, TGF-β1, and PDGF-B shown in Fig. 1. Here, TLR9 is linked to systemic lupus erythematosus.